UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Alibaba
BABA
|
+$2.55B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$459M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$316M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 5 |
GSK
GSK
|
+$251M |
Top Sells
| 1 |
Stellantis
STLA
|
+$991M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Apple
AAPL
|
+$315M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 5 |
Intel
INTC
|
+$283M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 8.49% |
| 4 | Healthcare | 7.86% |
| 5 | Industrials | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Voyager Therapeutics
VYGR
$237M
| $672K | ﹤0.01% |
142,485
+111,531
| +360% | +$526K |
|
3702
Cohen & Steers Closed End Opportunity Fund
FOF
$357M
| $670K | ﹤0.01% |
49,979
+6,890
| +16% | +$92.4K |
|
3703
United States Brent Oil Fund
BNO
$105M
| $667K | ﹤0.01% |
41,988
+14,133
| +51% | +$225K |
|
|
EXK
3704
Endeavour Silver
EXK
$1.96B
| $666K | ﹤0.01% |
134,324
-59,667
| -31% | -$296K |
|
|
ORC
3705
Orchid Island Capital
ORC
$1.02B
| $666K | ﹤0.01% |
22,169
+9,353
| +73% | +$281K |
|
|
NXGN
3706
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $665K | ﹤0.01% |
36,752
-6,244
| -15% | -$113K |
|
3707
Invesco S&P Spin-Off ETF
CSD
$77.8M
| $664K | ﹤0.01% |
10,554
-1,753
| -14% | -$110K |
|
3708
Tronox
TROX
$769M
| $662K | ﹤0.01% |
36,150
+14,153
| +64% | +$259K |
|
|
NML
3709
Neuberger Berman Energy Infrastructure and Income Fund
NML
$482M
| $661K | ﹤0.01% |
157,358
-34,753
| -18% | -$146K |
|
|
ITCI
3710
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $661K | ﹤0.01% |
19,462
-124
| -0.6% | -$4.21K |
|
3711
CTS Corp
CTS
$1.23B
| $660K | ﹤0.01% |
21,248
-3,921
| -16% | -$122K |
|
3712
Kiniksa Pharmaceuticals
KNSA
$2.62B
| $660K | ﹤0.01% |
35,643
+34,276
| +2,507% | +$635K |
|
3713
Invesco Municipal Income Opportunities Trust
OIA
$293M
| $660K | ﹤0.01% |
83,747
+2,005
| +2% | +$15.8K |
|
|
TIGR
3714
UP Fintech Holding
TIGR
$1.98B
| $660K | ﹤0.01% |
+37,123
| New | +$660K |
|
3715
DMC Global
BOOM
$154M
| $659K | ﹤0.01% |
12,156
-1,898
| -14% | -$103K |
|
3716
Compugen
CGEN
$124M
| $659K | ﹤0.01% |
76,688
+13,797
| +22% | +$119K |
|
|
IFN
3717
India Fund
IFN
$601M
| $659K | ﹤0.01% |
30,719
+2,478
| +9% | +$53.2K |
|
|
IVH
3718
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
| $659K | ﹤0.01% |
48,315
-4,151
| -8% | -$56.6K |
|
3719
First Trust S&P REIT Index Fund
FRI
$155M
| $658K | ﹤0.01% |
26,111
-10,812
| -29% | -$272K |
|
3720
iShares US Insurance ETF
IAK
$704M
| $658K | ﹤0.01% |
8,859
+70
| +0.8% | +$5.2K |
|
|
MDRX
3721
DELISTED
Veradigm Inc. Common Stock
MDRX
| $658K | ﹤0.01% |
43,798
-6,041
| -12% | -$90.8K |
|
3722
Helios Technologies
HLIO
$1.8B
| $657K | ﹤0.01% |
9,024
+636
| +8% | +$46.3K |
|
3723
Materion
MTRN
$2.5B
| $656K | ﹤0.01% |
9,910
+1,559
| +19% | +$103K |
|
3724
Nuveen Select Maturities Municipal Fund
NIM
$116M
| $655K | ﹤0.01% |
61,323
+1,481
| +2% | +$15.8K |
|
3725
Nuveen CA Select Tax-Free Income Portfolio
NXC
$82.9M
| $655K | ﹤0.01% |
40,200
+999
| +3% | +$16.3K |
|